Gold Member Since 2017
Audited Supplier
Changzhi Sanbao Biochemical Pharmaceutical Co., Ltd.

Edaravone, Pharmaceutical Chemicals, Chemicals manufacturer / supplier in China, offering Edaravone Active Pharmaceutical Ingredient From Alis Chemicals/89-25-8, Human Medicine Material API Supplier GMP Factory Streptomycin Sulfate, Chlorpheniramine Maleate Injection 25mg/Ml and so on.

(/ )

Supplier Homepage Product Injection Edaravone Active Pharmaceutical Ingredient From Alis Chemicals/89-25-8

Edaravone Active Pharmaceutical Ingredient From Alis Chemicals/89-25-8

FOB Price: US $0.1-100 / Box
Min. Order: 100 Boxes
Min. Order FOB Price
100 Boxes US $0.1-100/ Box
Get Latest Price
Port: Shanghai, China
Production Capacity: 500000 AMPS /Month
Payment Terms: L/C, T/T, D/P, Western Union, Paypal, Money Gram

Request a custom order and have something just for you!

Send Customized Request
Basic Info
  • Model NO.: powder for injection
  • Customized: Customized
  • Suitable for: Elderly, Children, Adult
  • Purity: >98%
  • Dosage: 5ml:10mg
  • Transport Package: Box
  • Origin: China
  • Powder: No
  • Certification: GMP, ISO 9001, USP, BP
  • State: Liquid
  • Use: Injection
  • Trademark: sunbiolab
  • Specification: 5ml
Product Description

Edaravone is a nootropic and neuroprotective agent used for the purpose of aiding neurological recovery following acute brain ischemia and subsequent cerebral infarction.It acts as a potent antioxidant and strongly scavenges free radicals, protecting against oxidative stress and neuronal apoptosis. It has been marketed solely in Japan by Mitsubishi Pharma since 2001.It is also marketed in India by Edinburgh Pharmaceuticals by the brand name Arone.

On June 26, 2015, Mitsubishi Tanabe Pharma Corporation announced it has received approval to market Radicut for treatment of ALS in Japan. The phase III clinical trial began in 2011 in Japan. The company was awarded Orphan Drug Designation for Radicut by the FDA and EU in 2015. Radicut is an intravenous drug and administrated 14 days followed by 14 days drug holiday.

The biotech company Treeway is developing an oral formulation of edaravone (TW001) and is currently in clinical development. Treeway was awarded orphan drug designation for edaravone by the EMA in November 2014 and FDA in January 2015.



Product NameEdaravone
CompositionEdaravone 10mg
StoreStore blew 25oC .Protect from light.
 Keep out of reach of children


Products NameProduction DescriptionSpecification
Depot Cyp 250
Testosterone Cypionate
Prop 100
Testosterone Propionate
Tren 100
Trenbolone Acetate
Trenbolone Enanthate
Send your message to this supplier
Mr. Kaide
To: Mr. Kaide

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

Find Similar Products By Category